Eddie Pan

Eddie Pan

Expertise: Institutional Investments, Insider Activity, Disruptive Innovations

Education: BBA, Finance, James Madison University

About Eddie:
Eddie Pan specializes in institutional investments and insider activity. He has been enamored with hedge funds since he began investing and regularly collaborates with industry executives to craft editorial pieces. Tracking the investments of institutional investors and insiders can provide a vast array of knowledge that is scarcely covered.

After receiving his BBA in Finance from James Madison University, Eddie began his career at Accenture as an analyst. Today, he writes for InvestorPlace’s Today’s Market team, which centers on the latest news involving popular stocks.

Eddie got his start in the financial media world by publishing articles on top-performing hedge funds and their investment strategies on Substack. He still publishes pieces on his Substack today.

Common Stocks and Uncommon Profits by Philip A. Fisher is Eddie’s favorite investment book. Fisher’s 15 Points have heavily influenced his investment strategy.

Recent Articles

PLTR Stock Alert: Why Did Palantir Just Hit a 52-Week Low?

Shares of PLTR stock hit a 52-week low this morning before rebounding slightly. What's in store for this well-known data analytics company?

fuboTV Just Reported Q4 Results: 7 Things to Know as FUBO Stock Slips

FuboTV announced full-year 2021 revenue guidance of $622 million to $627 million, up over 130% YOY. So, why is FUBO stock down today?

Tilray Price Predictions: Where Will TLRY Stock Go After Earnings Beat?

All eyes are on Tilray price predictions after the company reported earnings that reached profitability. Will 2022 be a turnaround story?

Loopring Price Predictions: Where Will GameStop NFT News Take the LRC Crypto?

All eyes are on Loopring and Loopring price predictions after GameStop announced it would be partnering with two undisclosed crypto companies.

CLOV Stock Alert: 4 Things to Know as Clover Health Hits an All-Time Low

Shares of Clover Health are declining today due to Humana lowering its membership forecast and Credit Suisse issuing a downgrade.